Shumilov, E., & Flach, J. (2019). Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations. Hematological oncology, 37, .
Chicago-Zitierstil (17. Ausg.)Shumilov, Evgenii, und Johanna Flach. "Critical Evaluation of Current Molecular MRD Strategies Including NGS for the Management of AML Patients with Multiple Mutations." Hematological Oncology 37 (2019).
MLA-Zitierstil (9. Ausg.)Shumilov, Evgenii, und Johanna Flach. "Critical Evaluation of Current Molecular MRD Strategies Including NGS for the Management of AML Patients with Multiple Mutations." Hematological Oncology, vol. 37, 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.